Select Page

Much like in 2015, the FDA quietly sent warning letters to several (CBD) oil manufacturers located throughout the United States in early February of this year. In both instances, the letters were issued after test results revealed that the products were falsely labeled.

The letters encourage these companies to “take prompt action to correct the violations” in an effort to avoid legal complications for making false claims about the products’ ingredients. Moreover, the warning seem fairly warranted when you read that the FDA claims it tested many of these products and many of these products showed no traces of CBD in them at all.

That’s a dangerous game to play, and it’s very noteworthy that the FDA is testing CBD products. And it could have either a very positive or a very negative impact on the CBD industry.

The FDA is doing its job by making sure false products stay out of patients’ hands in need of real CBD and real medicine. It’s the FDA’s job to regulate pharmaceutical claims, and if there are no traces of CBD in some of these products, then these products deserve to be wiped off the market.

CBD has known medical powers to stop seizures, help cancer patients, and a myriad of other known health benefits. But when there is no CBD in “CBD products”, a natural problem and a systematic epidemic occurs.

That epidemic isn’t new. While many companies in Colorado and beyond are making real, impactful CBD medicines, not all are. Many import very weak “hemp CBD” from China and make products that have barely a trace of CBD in them. That becomes a problem when real patients are buying these products.

For instance, some of these products claim they’re helpful for seizures, arthritis, MS, and diabetes, so unsuspecting consumers will buy them. But when the FDA tests them, and finds not even a hint of CBD within these products, that’s when they’re revealed as true snake oil.

Michael Felberbaum, a spokesman for the FDA, released this statement regarding the pivotal issue:

“The companies receiving these warning letters were selected, in part, based on the egregiousness of the claims made about their products and the determination that inaction posed a potential risk to public health

That quote is telling for companies making real CBD products. That quote makes it seem clear that the FDA won’t go after companies that are providing real medicine with actual CBD within it.

This story has gone semi-viral over the concern that the FDA is going to monitor and monopolize all CBD products through big pharmaceutical companies. Fortunately, that appears to be very far from the truth. The FDA is merely doing its job and telling companies going about this game the wrong way to cut out the charades–or face serious penalties.

That’s a major positive: companies selling fake CBD should all be taken to the shed outback and destroyed. While there is fair and real concern that these letters could pave the way for further FDA regulation of the CBD-industry, this quote from Felberbaum hints that that’s not a huge issue just yet:

“The federal government is supportive of scientific research into the medical uses of marijuana and its constituents, through scientifically valid investigations as part of the FDA’s drug review and approval process”

Every industry needs a watchdog, and while the FDA is a scary watchdog for the cannabis industry to have, it’s far better than the alternative. All of the companies listed from 2015 and 2016 are not legit, known industry companies.

In fact, many of them are selling hemp CBD products targeting pets. That means they’re targeting unsuspecting consumers and selling a flat-out junk placebo. Here are those companies that you and your friends should steer clear of, via the FDA:

fda warning letters cbd companies

As noted previously, there isn’t a single well-known company on that list. That means that many of these may be “snake oil”, scam companies with no real relationship to the legitimate cannabis industry.

Unfortunately for the CBD industry, there will always be snakes in the thick weeds out there trying to pounce on this extremely side of the cannabis world. But oddly enough, the FDA has stood up and is helping weed out the pretenders from the contenders.

Thus, this “ordeal” should be viewed more as a positive for the future of CBD than anything else.

Bernie Canter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Share This
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']